VIL's premium multiples should sustain during the turnaround, Jefferies said adding that VIL's network investments are ...
Investors are no longer viewing emerging market private credit as a niche allocation but as a strategy part of private market ...
AeroVironment delivered a blowout first quarter of fiscal 2027, reporting record revenue of $480 million — up 21% year-over-year — and a record ...
On 2, Michael Genovese from Rosenblatt Securities reiterated his Neutral rating for Credo Technology Group Holding Ltd ...
In an interview with CNBC, CEO Michael Intrator said the company’s long-term offtake agreements and deal-level economics ...
Artificial intelligence has reached a consumer inflection point. According to a new survey from TD, more than 78% of ...
15h
Oregon lawmakers preview Kotek’s prosperity council findings amid economic ‘inflection point’
The council used recommendations earlier this year to slash taxes, reduce regulations and spur economic development in the state, but its findings are facing skepticism from the right and left. SALEM ...
Biogen CEO Christopher Viehbacher joins 'Squawk on the Street' to discuss their upcoming product pipeline, developments in ...
Korn Ferry is a Buy with ~10% upside to a $90 PT, supported by resilient executive search and improving labor market trends. Click for more on KFY stock.
Securing a dominant strategic foothold in the fast-expanding 100-billion-scale industry track has emerged as a core priority ...
Archer-Daniels-Midland is positioned to benefit from an emerging agro-commodity supercycle, supported by macro tailwinds. See ...
Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the appointments of Donald Hayden, M.B.A., as Chairman and Michael MacLean as independent director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results